Why Are More Women Having Mastectomies?
In 2013, actress Angelina Jolie elected to undergo a double mastectomy after testing positive for the BRCA1 gene mutation. This mutation greatly increases the risk for breast cancer. The star encouraged other women to get tested for BRCA1, and it appears many did.
FDA Expands Indication For Breast Cancer Rx
On February 19, 2016, the U. S. Food and Drug Administration approved palbociclib (IBRANCE Capsules, Pfizer, Inc.) in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
The Effect of BRCA Testing on Breast Cancer Treatment
Genetic testing in younger women with breast cancer may be getting more common. And that could have an effect on those women's future treatment decisions.
When Should Women with DCIS Get Radiation?
What if there was a way to predict which cancer patients would benefit from radiation therapy? New evidence suggests, for one type of breast cancer, there could be.
Nothing Compares to Mother’s Milk
What would happen if nearly every mother around the world breastfed her babies? Great things, new evidence suggests.
What Would You Risk for a Tan?
Many young women use tanning beds before swimsuit season begins to get some extra color. But these women may want to opt for a safer method.
What You Need to Know About the HPV Vaccine
January is Cervical Health Awareness Month, a time to raise awareness about how women can protect themselves from HPV and cervical cancer.
New Hope for Fertility After Cancer
Young women with invasive breast cancer are often faced with a difficult choice: whether or not to undergo chemotherapy despite its risk of infertility.
A Hormone Therapy Benefit for Postmenopausal Women
Hormone therapy is often used to ease symptoms like hot flashes in postmenopausal women. But this practice may have another benefit.
Breast Cancer Rxs Go Head to Head
The current front-line treatment for early breast cancer, tamoxifen, may have met its match.